Did anyone check that news story on our own Frank Baldino Jr., a Board of Trustees member who founded Cephalon Inc., a biotechnology and pharmaceuticals company, as reported by The Temple News?

The dude is getting sued by the Federal Trade Commission for what it calls “anti-competitive conduct.” Allegedly, Cephalon made an agreement with other companies to delay generic (*cheaper) production of the company’s Provigil, a sleep disorder drug.

Sounds a little peculiar, something that might originate behind closed doors in South Philly. Check this editorial cartoon video by TTN staffers.

[youtube:http://www.youtube.com/watch?v=d-QGRKu_-xU 350 292]